Radiopharmaceutical Supply and Dosing

The contract calls for the supply of 10.0 mCi intravenous doses of Amyvid (Florbetapir F 18) to support PET imaging needs at the VA Medical Center in East Orange, New Jersey, on an as-needed basis. This subcontract is part of the Department of Veterans Affairs’ efforts to ensure timely access to diagnostic radiopharmaceuticals for clinical use, specifically for amyloid imaging in patients with cognitive impairment. The supplier must be prepared to deliver the doses promptly to meet varying operational demands without a fixed schedule, requiring flexible logistics and reliable production capabilities. The solicitation was posted on May 1, 2026, with responses due by 2:00 PM Eastern Time on May 6, 2026. The contract falls under NAICS code 325412, which pertains to the manufacturing of radiopharmaceuticals, indicating the supplier must be a certified and qualified producer of F-18 labeled compounds. Performance is required exclusively at the East Orange VA facility, and while no set-asides or specific eligibility criteria are outlined, bidders are expected to demonstrate compliance with federal radiopharmaceutical handling, transportation, and quality control standards. The contract emphasizes reliability, precision in dosing, and adherence to strict nuclear medicine protocols to ensure patient safety and diagnostic accuracy.